SPA
SRTA

Sherbrooke Park Advisers’s Strata Critical Medical Inc SRTA Stock Holding History

Sherbrooke Park Advisers’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,008
Closed -$51K – 628
2024
Q4 		$51K Sell
12,008
-98,422
-89% -$375K 0.02% 709
2024
Q3 		$325K Buy
110,430
+38,755
+54% +$123K 0.07% 536
2024
Q2 		$249K Sell
71,675
-34,232
-32% -$114K 0.04% 697
2024
Q1 		$302K Buy
105,907
+93,512
+754% +$289K 0.06% 566
2023
Q4 		$43.8K Buy
+12,395
New +$35.6K 0.02% 436

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sherbrooke Park Advisers's SRTA Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Strata Critical Medical Inc (SRTA) in Q1 2025, closing a stake of 12,008 shares — an estimated $51K sold.

Sherbrooke Park Advisers first reported a position in SRTA in Q4 2023 and held it in 5 quarters. The position peaked at $325K in Q3 2024. 118 funds tracked by Wall St. Rank hold SRTA as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Strata Critical Medical Inc position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 12,008 Strata Critical Medical Inc shares in Q1 2025, an estimated $51K.
  • Sherbrooke Park Advisers first reported a position in Strata Critical Medical Inc in Q4 2023 and held it in 5 quarters.
  • Sherbrooke Park Advisers's Strata Critical Medical Inc position peaked at $325K in Q3 2024.
  • 118 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.